Cargando…

DDEL-01. ENHANCING DRUG DELIVERY WITH MRgFUS FOR DIFFUSE INTRINSIC PONTINE GLIOMA MODEL

Diffuse intrinsic pontine glioma (DIPG) is a surgically unresectable and devasting tumor in children. To date, there have been no effective chemotherapeutics despite a myriad of clinical trials. The intact blood-brain barrier (BBB) in part is responsible for the limited clinical response to chemothe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ishida, Joji, Alli, Saira, Bondoc, Andrew, Golbourn, Brian, Sabha, Nesrin, Mikloska, Kristina, Srikanthan, Dilakshan, Luck, Amanda, Smith, Christian, Hynynen, Kullervo, Rutka, James
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Drug Delivery/Pharmacokinetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7715653/ http://dx.doi.org/10.1093/neuonc/noaa222.036

Ejemplares similares

DDEL-12. NANOPARTICLE DELIVERY OF DOXORUBICIN FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
por: Ung, Caitlin, et al.
Publicado: (2020)

DDEL-11. CONVECTION-ENHANCED DELIVERY OF EZH2 INHIBITOR FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA
por: Sasaki, Takahiro, et al.
Publicado: (2020)

DDEL-08. CONVECTION-ENHANCED DELIVERY OF NIMUSTINE HYDROCHLORIDE (ACNU) AGAINST PEDIATRIC DIFFUSE INTRINSIC PONTINE GLIOMAS
por: Saito, Ryuta, et al.
Publicado: (2020)

DDEL-05. BLOOD-BRAIN BARRIER DISRUPTION AND ENHANCED RADIOSENSITIZERS EXTRAVASATION UPON FOCUSED ULTRASOUND FOR TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMA
por: Hart, Elvin ‘t, et al.
Publicado: (2020)

DDEL-13. FOCUSED ULTRASOUND MEDIATED BLOOD BRAIN BARRIER DISRUPTION IN A MURINE MODEL OF PONTINE GLIOMA: A SAFETY AND FEASIBILITY STUDY
por: Englander, Zachary, et al.
Publicado: (2020)

Immune activation and MRgFUS
por: Ferrara, Katherine, et al.
Publicado: (2015)

DDEL-17. TRIPLE INTRAVENTRICULAR CHEMOTHERAPY FOR TREATMENT OF RELAPSED CHOROID PLEXUS CARCINOMA
por: Lau, Grace, et al.
Publicado: (2020)

DDEL-04. ENGINEERED NANOCARRIERS TO ENHANCE DRUG DELIVERY ACROSS THE BLOOD-BRAIN BARRIER
por: Straehla, Joelle P, et al.
Publicado: (2020)

DDEL-02. Intra-arterial Delivery for Novel Combinatorial Chemotherapies in Choroid Plexus Carcinoma
por: Martin, Brice, et al.
Publicado: (2022)

Comparison of computer simulations and clinical treatment results of magnetic resonance‐guided focused ultrasound surgery (MRgFUS) of uterine fibroids
por: Hyvärinen, Mikko, et al.
Publicado: (2022)

DDEL-15. NANOTHERAPEUTIC TARGETING OF TUMOR ENDOTHELIUM FOR ENHANCING DRUG DELIVERY PAST THE BLOOD-BRAIN BARRIER
por: Kiguchi, Hiro, et al.
Publicado: (2020)

DDEL-14. SAFETY OF INTERVENTRICULAR METHOTREXATE ADMINISTRATION FOLLOWING RADIATION IN PEDIATRIC PATIENTS WITH MALIGNANT BRAIN TUMORS
por: Rosales, Kristofer, et al.
Publicado: (2020)

MRgFUS of osteoid osteoma started at the Rizzoli
por: Bazzocchi, Alberto, et al.
Publicado: (2014)

ET-04 Enhancing drug delivery with MRI-guided focused ultrasound for diffuse intrinsic pontine glioma model
por: Ishida, Joji, et al.
Publicado: (2020)

DDEL-03. The use of programmable valves as a vehicle for intrathecal chemotherapy delivery in infants with CNS tumors and hydrocephalus.
por: Dvir, Rina, et al.
Publicado: (2022)

DDEL-10. A NANOPARTICLE PLATFORM FOR INTRATHECAL DELIVERY OF THE HISTONE DEACETYLASE INHIBITOR (HDACi) PANOBINOSTAT IN METASTATIC OR RECURRENT MEDULLOBLASTOMA
por: Chaudhuri, Sauradip, et al.
Publicado: (2020)

DDEL-05. Intraventricular therapy with topotecan is feasible and safe: Experience in 50 pediatric patients with various malignant brain tumors
por: Peyrl, Andreas, et al.
Publicado: (2022)

DDEL-06. Drug Delivery to the Pons Using Short-Pulse Focused Ultrasound and Microbubble Exposure for the Treatment of Diffuse Midline Glioma
por: Chattenton, Dani, et al.
Publicado: (2022)

DDEL-03. LONG-TERM INTRAVENTRICULAR THERAPY ALTERNATING ETOPOSIDE AND LIPOSOMAL CYTARABINE: EXPERIENCE IN 75 CHILDREN AND ADOLESCENTS WITH MALIGNANT BRAIN TUMORS
por: Stepien, Natalia, et al.
Publicado: (2020)

DDEL-06. DRUG INTERACTION BETWEEN EVEROLIMUS AND CANNABIDIOL IN PEDIATRIC PATIENTS WITH SUBEPENDYMAL GIANT CELL ASTROCYTOMAS: A SINGLE INSTITUTION EXPERIENCE
por: Sabus, Ashley, et al.
Publicado: (2020)

DDEL-09. HIGH DOSE MTX110 (SOLUBLE PANOBINOSTAT) SAFELY ADMINISTERED INTO THE FOURTH VENTRICLE IN A NON-HUMAN PRIMATE MODEL
por: Sirianni, Rachael W, et al.
Publicado: (2020)

Software-supported analysis of MRgFUS therapy outcome
por: Corr, Doerte, et al.
Publicado: (2015)

The effect of reimbursement on MRgFUS treatment of uterine fibroids
por: Machtinger, Ronit, et al.
Publicado: (2015)

MRgFUS for Uterine Myomas: Safety, Effectiveness and Pathogenesis
por: Kurashvili, Julia, et al.
Publicado: (2014)

DDEL-16. UNDERSTANDING OPTIMAL CONVECTION-ENHANCED DELIVERY PHYSICO-CHEMICAL INFUSION PARAMETERS: THE ROLE OF BBB EFFLUX PUMPS IN DRUG DISTRIBUTION AND CLEARANCE
por: Power, Erica, et al.
Publicado: (2020)

DDEL-07. A PHASE I STUDY EXAMINING THE FEASIBILITY OF INTERMITTENT CONVECTION-ENHANCED DELIVERY (CED) OF MTX110 FOR THE TREATMENT OF CHILDREN WITH NEWLY DIAGNOSED DIFFUSE MIDLINE GLIOMAS
por: Zacharoulis, Stergios, et al.
Publicado: (2020)

MRgFUS treatment of superficial osteoid osteomas of the lower limbs
por: Bazzocchi, Alberto, et al.
Publicado: (2015)

Radiological and Thermal Dose Correlations in Pallidothalamic Tractotomy With MRgFUS
por: Gallay, Marc N., et al.
Publicado: (2019)

Simple methods to test the accuracy of MRgFUS robotic systems
por: Antoniou, Anastasia, et al.
Publicado: (2021)

Full coverage path planning algorithm for MRgFUS therapy
por: Antoniou, Anastasia, et al.
Publicado: (2022)

DDEL-07. A Phase I study examining the feasibility of intermittent convection-enhanced delivery (CED) of MTX110 for the treatment of children with newly diagnosed diffuse midline gliomas (DMGs)
por: Zacharoulis, Stergios, et al.
Publicado: (2022)

DDEL-04. Pharmacokinetic/Pharmacodynamic analysis of the DNA methyltransferase inhibitor 5-azacytidine shows adequate brain tissue penetration with intravenous administration in a DIPG mouse patient-derived xenograft model.
por: Groves, Andrew, et al.
Publicado: (2022)

DDEL-02. DECREASED TOXICITY OF CONVENTIONAL DOSE CHEMOTHERAPY UTILIZING BODY WEIGHT INSTEAD OF BODY SURFACE AREA FOR DOSING IN YOUNG CHILDREN <6 YEARS OLD ENROLLED ON THE “HEAD START” 4 CLINICAL TRIAL
por: Dhall, Girish, et al.
Publicado: (2020)

Characterization and evaluation of tissue-mimicking gelatin phantoms for use with MRgFUS
por: Farrer, Alexis I., et al.
Publicado: (2015)

Evaluation safety and efficacy of MRgFUS for palliative treatment of bone metastasis
por: Turkevich, Vladimir, et al.
Publicado: (2014)

MRgFUS for desmoid tumors within the thigh: early clinical experiences
por: Bucknor, Matthew D., et al.
Publicado: (2017)

Needleless Ablation of Osteoid Osteoma and Osteoblastoma: The Emergent Role of MRgFUS
por: Cobianchi Bellisari, Flavia, et al.
Publicado: (2021)

MRgFUS new applications in musculoskeletal pathology: a miscellaneous case review
por: Bazzocchi, Alberto, et al.
Publicado: (2015)

Clinical trial update: treatment of metastatic brain tumors using MRgFUS
por: Monteith, Stephen, et al.
Publicado: (2015)

Setting up a new MRgFUS service for fibroids - the challenges and solutions
por: Crowe, Paul M, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_baa8ic7ltoj1ulfhraukdvi5sa